Skip to main content

Table 3 Past medical history of the study's participants

From: Compliance with the north American Society of Pacing and Electrophysiology guidelines on amiodarone monitoring in Riyadh, Saudi Arabia: a retrospective charts review study

Comorbidity N (%)
HypertensionLung disease
108 (75.5)32 (22.4)
Diabetes mellitusRenal disease
94 (65.7)49 (34.3)
DyslipidemiaLiver disorder
48 (33.6)11 (7.7)
Myocardial infractionMalignancy
47 (32.9)18 (12.6)
Coronary artery diseaseGout
89 (62.2)2 (1.4)